ESOKALLI Delay Performance Gel
ESOKALLI Delay Performance Gel · LIDOCAINE .1 g/100mL; ARGININE 2 g/100mL · Gel · Topical · Guangzhou Yixin Cross-border E-commerce Co., Ltd.
NDC 84778-0103-01 · 1 TUBE in 1 BOX / 1.8 mL in 1 TUBE · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- 505G(a)(3)
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of ESOKALLI Delay Performance Gel (Gel)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Guangzhou Yixin Cross-border E-commerce Co., Ltd. | LIDOCAINE .1 g/100mL; ARGININE 2 g/100mL | Jul 22, 2026 | Jul 29, 2026 |
| Guangzhou Yixin Cross-border E-commerce Co., Ltd. | ARGININE .1 g/100mL; LIDOCAINE 2 g/100mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "ESOKALLI Delay Performance Gel — NDC 84778-0103-01," retrieved September 3, 2026, https://drugdashboards.com/drug/84778010301.
Free to cite with attribution — see how the data is put together.